VerbatimParliament, as it happens

Skin Diseases: Steroid Drugs

Asked by Damien EganLabourDepartment of Health and Social CareTabled Answered 7 April 2026UIN 123425

The question

To ask the Secretary of State for Health and Social Care, whether NHS England has assessed the potential merits of a dedicated referral and support pathway for patients experiencing Topical Steroid Withdrawal, distinct from standard eczema care.

Answered by Karin Smyth

There has been no national assessment of need for a dedicated referral and support pathway for topical steroid withdrawal (TSW). Care for patients presenting with TSW is provided through services commissioned by individual integrated care boards.

The Elective Reform Plan, published January 2025, outlines actions that will help ensure care is delivered in the right place. This includes expanding the use of Advice and Guidance, a clinical collaboration tool that supports timely specialist input and helps patients receive care in the right setting, including for dermatology care.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim